Quantcast

Latest Ornithine Stories

2013-12-05 23:28:46

Esteemed Wellness Company Releases Latest L-Arginine Amino Acid Complex to Help People Achieve Better Overall Health, Enhanced Circulation, Cardiac Health, Workout Recovery and Muscle Development. Dalvia Wellness Labs (PRWEB) December 05, 2013 Dalvia Wellness Labs, a US-based company known for offering high-end quality health and wellness products, has announced the launch of its latest product – Dalvia L-Arginine Amino Acid Complex Powder, now at Amazon.com According to the company,...

2013-10-31 23:20:15

New applications expand for anti-fatigue ingredient. New York, NY (PRWEB) October 31, 2013 Kyowa Hakko U.S.A., Inc. (Kyowa Hakko USA), the wholly-owned subsidiary of Kyowa Hakko Bio Co., Ltd., (Kyowa), has announced it has completed GRAS (Generally Recognized As Safe) self-affirmation for the valuable amino acid L-Ornithine. L-Ornithine is an amino acid that is used to build muscle by stimulating protein synthesis through the enhancement of growth hormone secretion and to assist weight...

2011-05-12 00:06:42

The urea cycle is a metabolic pathway used in mammals to incorporate excess nitrogen into urea and remove it from the body. However, it appears to play a far more wide-ranging role in the group of algae known as diatoms. Scientists from the Max Planck Institute of Molecular Plant Physiology in Potsdam are part of an international team of researchers that has succeeded in identifying the urea cycle in diatoms as a distribution and recycling centre for inorganic carbon and nitrogen. The urea...

2011-03-10 19:12:00

LAS VEGAS, March 10, 2011 /PRNewswire/ -- HCG Fast Trim and SterkHealth, LLC, are giving away a one-year free gym membership to promote the launch of HCG Fast Trim and a healthier 2011. Newly launched in 2011, HCG Fast Trim is a homeopathic appetite suppressant and weight loss product that combines amino acids and HCG that are naturally produced in the human body to amplify fat metabolism. HCG Fast Trim contains the amino acids Arginine, Carnitine and Ornithine. Each ingredient in this...

2009-06-30 07:00:00

SOUTH SAN FRANCISCO, Calif., June 30 /PRNewswire/ -- Hyperion Therapeutics, a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs in the areas of gastroenterology and hepatology, today announced it has closed a $60 million Series C financing. New investors Bay City Capital and Panorama Capital co-led the financing. Series A and B investors Highland Capital Partners, NEA, and Sofinnova Ventures also participated. (Logo:...

2009-05-05 07:00:00

- Company preparing to initiate phase III clinical trial - SOUTH SAN FRANCISCO, Calif., May 5 /PRNewswire/ -- Hyperion Therapeutics, Inc. today announced that HPN-100 has received orphan product designation from the U.S. Food and Drug Administration for maintenance treatment of patients with enzymes of the urea cycle. The Company recently announced results from its phase II study and intends to initiate a phase III clinical program in this indication in the second half of 2009. (Logo:...

2008-11-12 09:00:45

SOUTH SAN FRANCISCO, Calif., Nov. 12 /PRNewswire/ -- Hyperion Therapeutics, Inc. today reported completion of data analysis for its Phase 2 clinical trial designed to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 versus BUPHENYL(R) (sodium phenylbutyrate), the current standard of care in patients with urea cycle disorders. Data from the trial will be presented at an upcoming medical conference. (Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)...

2008-07-23 09:01:21

Hyperion Therapeutics has completed patient enrollment in its Phase I/II clinical trial to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 versus Buphenyl in patients with urea cycle disorders. The company plans to announce top-line results in the fourth quarter of 2008. HPN-100 is a pro-drug of phenylbutryrate and a pre-pro-drug of phenylacetic acid, the active moiety of Buphenyl, the only therapy currently FDA-approved as adjunctive therapy for the chronic...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related